Goal Directed Therapy After Aneurysmal Subarachnoid Haemorrhage

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 108 participants.

Also called NCT01832389

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 108 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01832389
Other papers using this trial's data
  • Impact of Goal-Directed Therapy on Delayed Ischemia After Aneurysmal Subarachnoid Hemorrhage: Randomized Controlled Trial Stroke, 2020-08 DOI, PubMed 32640940 PubMed links an erratum for this paper. Erratum: PMID 32833606

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Germany (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01832389. Randomized; no masking; primary purpose treatment. Start 2013-03 (registry gives no type); primary completion 2015-11 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Goal Directed Therapy After Aneurysmal Subarachnoid Haemorrhage
Acronym
PiSAH
Condition
Aneurysmal Subarachnoid Haemorrhage
Condition
SAH
Intervention (Device)
PiCCO
Lead sponsor
Technical University of Munich (class: other)

Record details

Record id
cardio:ct-nct01832389
Content hash
0847bc024947857ecb0b6e49988198298efb72a627c838f950936dd2b83a11e5